ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Blue Chip Shares
Why analysts love these ASX 200 blue chip shares
Blue Chip Shares
3 ASX 200 shares with major upside potential in 2022
Growth Shares
Analysts think growth investors should buy these ASX shares right now
Blue Chip Shares
3 strong blue chip ASX 200 shares to buy
Broker Notes
Leading brokers name 3 ASX shares to buy today
Healthcare Shares
2 healthcare ASX shares that Morgans loves right now
Growth Shares
2 ASX shares with strong long term growth potential
Ask a Fund Manager
Advisor reveals the 3 most popular ASX shares among his clients
Broker Notes
2 ASX shares looking good in turbulent times
Broker Notes
Why a leading broker is bullish on these 3 ASX shares
Growth Shares
Analysts name 2 fantastic ASX 200 shares to buy
Broker Notes
Analysts name 3 ASX shares to buy now
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
